Accès membre
Logo Groupe FILO

National Cooperative Group
of research in the field of Chronic Lymphoid Leukemia (CLL) Acute Myeloblastic Leukemia (AML)

Cooperative Group presentation

FILO is a Cooperative Group aiming at implementing and carrying out biomedical, epidemiological, clinical, pharmacological and biological research in the field of Chronic Lymphoid Leukemia (CLL), Waldenström's Disease (MW), Acute Myeloblastic Leukemia (LAM) and other pathological conditions such as Myeloproliferative Syndromes. It also endeavors to pursue educational and / or informative actions intended for medical professionals and patients.

Read More ...
Pictogramme chercheur
Médecin et un patient - Groupe FILO

All news

More details

News


Le FILO à l'honneur à l'ASH 2017!

FILO Groups honored at ASH!

Pr Pierre Feugier has just presented orally at the ASH (American Society of Hematology) which takes place in Atlanta between 08th and 12th of December 2017 the first results of the ICLL07 GAI trial. This trial included patients with CLL disease requiring a 1st line of treatment. The first part of treatment consists of combination of Obinutuzumab (new generation ...


Du nouveau pour IMBRUVICA ®

New for IMBRUVICA ®

New for IMBRUVICA® (ibrutinib), a Bruton tyrosine kinase inhibitor (BTK) already widely used in CLL and Mantle Cell Lymphoma.

All news
Microscope, Chercheurs, Leucémie